What does our testing process look like? Scroll through our thread for a look into our process.
From sample collection to consultation, our tests are designed to simplify heart attack risk assessment and the diagnosis of coronary heart disease (CHD) so that you can take more proactive control of your heart health.
Learn more here: https://t.co/e5WgOXzYF9
#LaboratoryWorkflow #ClinicalLaboratory #MachineLearning #PrecisionMedicine
Today is National Rural Health Day, a day to bring focus to the importance of driving healthcare access in rural communities.
Rural Americans make up about 13.6% of the U.S. population in 2024, according to a report published by the @USDA_ERS in 2026. But despite serving a key demographic, rural counties have fewer health care workers, specialists (such as cardiologists), critical care units, emergency facilities, and transportation options (@CDCgov).
With limited operational resources and access challenges, it’s not surprising that rural communities face a higher prevalence of chronic disease (@CDCgov). In fact, coronary heart disease is approximately 20% higher in rural areas than in urban areas (Kulshreshtha et al., Public Health Reports, 2014).
At Cardio Diagnostics, we believe that access to advanced cardiovascular medicine shouldn’t depend on your zip code. Our report on the State of Rural Hospitals and Cardiovascular Care defines key opportunities to strengthen heart health in rural areas. Read it here: https://t.co/Db7HJUfEfs
#NationalRuralHealthDay #RuralHealthcare
What if we could implement advanced cardiovascular testing in primary care?
Strategies for detection and management of coronary heart disease have long relied on diagnostic tools such as imaging that require specialist referrals.
But what if there was a more accessible way to help identify an individual’s likelihood of undergoing a serious cardiac event, or detecting the presence of coronary heart disease?
Our clinical blood tests empower physicians to bring advanced cardiovascular solutions to primary care, helping support insights into heart attack risk and coronary heart disease sooner.
Learn how our tests support earlier and more targeted interventions: https://t.co/AtiiviLOlg
#PrimaryCare #PreventiveMedicine #HeartDisease #PhysicianPractice
A coronary angiogram can miss the full clinical picture of coronary heart disease.
Non-obstructive coronary artery disease (NOCAD) describes patients with symptoms of coronary disease but no significant blockage in the large coronary arteries. NOCAD cannot be detected by invasive coronary angiography alone. Increased awareness of patients with NOCAD and strategies for identifying these individuals are necessary.
Our latest whitepaper by Robert Philibert, MD, PhD, discusses the limitations of angiography for NOCAD patients, and offers a precision medicine lens to bridge this gap in the diagnosis and management of NOCAD patients.
Download the whitepaper here: https://t.co/yKWhOqnpmI
#NonObstructiveCAD #INOCA #HeartDisease
Can chronic sleep loss impact how your genes are expressed?
Through epigenetics, we can reveal how lifestyle and environment interact with our genes to leave clues related to our health — including the cost of poor sleep hygiene.
Researchers at @uppsalauni in Sweden found that a single night without sleep changed how genes were regulated in fat and muscle tissue, in ways linked to fat storage and muscle loss.
The takeaway: The effects of sleep loss may be unsuspecting, but it has been demonstrated to result in epigenetic changes in fat tissue and increase inflammation across tissues.
Explore the science of how your lifestyle and habits can influence your health: https://t.co/VzTkRQzHOH
#Epigenetics #ScienceFacts #SleepHealth
In the latest episode of the Petri Dish Perspectives podcast, our CEO and Co-Founder, Meesha Dogan, PhD, dives into our company history, epigenetics and its role in shaping coronary heart disease detection and management, future industry trends, and much more. Listen to the full episode here: https://t.co/JvVU7a1vAy
When a heart attack takes place, it doesn’t always announce itself. In fact, about one in five heart attacks are silent, with mild or no symptoms (@CDCgov). Knowing the signs of a silent heart attack and your own cardiovascular risk is essential to prevention. Learn the signs and how precision medicine can help identify hidden risks of a heart attack. Read more: https://t.co/GTmOdu42Nl
#SilentHeartAttack #Cardiology #HeartHealth
Employers can expect health benefit costs to go up 8.2% per employee in 2027. This marks the fifth consecutive year of escalating costs, challenging employers to develop strategies to minimize shifting the cost burden to employees.
Developing strategies that focus on high-cost claims continues to be the top priority for employers surveyed by @MarshGlobal, with 89% designating it as very important or important.
At Cardio Diagnostics, we help employers tackle high-cost claims that arise from cardiovascular disease, a leading driver of claims and medical costs (@CDCgov). Our precision medicine solutions help employees improve their cardiovascular health and prevent life-threatening cardiac events, while helping employers avoid high-cost claims.
Learn how we work with employers: https://t.co/t8ZEr2J4cv
#EmployeeBenefits #HealthBenefits #BenefitsStrategy
Roughly 1 in 4 women with acute coronary syndrome (ACS) don't present with chest pain, according to a study by van Oosterhout et al. published in @JAHA_AHA in 2020. ACS can manifest as unstable angina or heart attacks caused by a partial or complete coronary artery blockage.
While chest pain was the most common symptom experienced by women with ACS, they were more likely to present with less suspecting symptoms such as pain between the shoulder blades, nausea or vomiting, and shortness of breath. These symptoms can be easily overlooked, and waiting for them isn’t a strategy.
That’s why assessing risk before symptoms ever appear is key. For women with no signs of coronary heart disease, Epi+Gen CHD™ helps you and your provider have insight into your three-year risk of a coronary heart disease event, including a heart attack. It analyzes genetic and epigenetic biomarkers using AI, delivering a risk assessment that’s demonstrated to be more sensitive than conventional risk calculators.
Learn about how epigenetic-genetic testing can improve insight into heart health for women: https://t.co/1tajDsT4aw
#CardiovascularDisease #WomensHealth #HeartAttack #HealthEquity
What if you could learn not just whether a signal associated with coronary heart disease (CHD) is present, but what’s driving it?
PrecisionCHD™ is a simple clinical blood test that helps uncover the specific molecular drivers of CHD for each patient, without requiring radiation or fasting.
When you test with PrecisionCHD, your ordering provider receives a report that explains the “why” behind your results, such as lifestyle and environmental drivers that may be contributing to disease.
Get more personalized and better-informed care to manage your disease with PrecisionCHD: https://t.co/unqztv2cJp
Did you know? AI applications in medicine are less novel than you might think. Theoretical applications began as early as the 1950s, and use cases have since grown more complex, expanding into real-world areas such as surgery, disease diagnosis, and genomic research.
One of the earliest and most widely recognized medical AI expert systems was MYCIN, developed at Stanford University in the mid-1970s to diagnose and treat bacterial infections.
Today, AI-based solutions have surged across healthcare, bringing significant opportunity but also complexity. It's critical that healthcare organizations understand the purpose behind a given AI use case before adopting it.
Cardio Diagnostics pioneered the first AI-driven multi-omics engine for precision cardiovascular medicine. Our blood tests combine epigenetics, genetics, and AI to reshape how we assess an individual’s likelihood of having a heart attack or developing coronary heart disease. Learn more about our advanced technology here: https://t.co/meeh70Yj1l
#AIHistory #ScienceHistory #HealthTech
We’re looking forward to exhibiting at the @IFEBP's Annual Employee Benefits Conference from October 25-28 in New Orleans. We’re excited to connect with benefit professionals and industry leaders to discuss how our solutions can help strengthen benefit strategies and enhance health outcomes for organizations.
Our evidence-based blood tests for the prevention and early detection of coronary heart disease provide employees with a deeper understanding of their heart health. We seamlessly integrate into an organization’s workflow and manage test program logistics end-to-end, from pre-testing education to post-testing support. The results support a healthier, informed workforce equipped with insights to actively take charge of their health, while help organizations reduce total healthcare spend.
Interested in learning more about how our tests can strengthen employee heart health within your organization and help your organization reduce spend? Connect with us at Booth 220 at the conference.
#IFAnnual #EmployeeBenefits
While aerobic exercise is typically associated with heart health, is it the best form of exercise for your heart? Scroll through our thread to learn about how different types of exercise can improve your heart health.
#AerobicExercise#CardiovascularHealth